ZNF711-Related XLMR

The Ambry Test: ZNF711-Related XLMR includes gene sequence analysis of the ZNF711 gene. Testing is also available for individual mutations in families in which a specific ZNF711 mutation has previously been identified.

PrintPrint

The Ambry Test: ZNF711-Related XLMR includes gene sequence analysis of the ZNF711 gene. Testing is also available for individual mutations in families in which a specific ZNF711 mutation has previously been identified.

Next-Gen Sequencing of  ZNF711 is also available as part of Ambry's XLMR Next-Gen SuperPanel™. It cannot be ordered separately. 

Disease Name 
X-Linked Intellectual Disabilities
ZNF711-Related XLMR
Disease Information 

Mental retardation (MR) involves a complex collection of clinically and genetically diverse disorders. Diagnosis of MR is typically based on three main criteria: onset of symptoms before the age of 18, intellectual abilities significantly lower than average, and reduced adaptive skills. Individuals with MR tend to struggle in areas including communication, health, interpersonal/social skills, leisure, safety, self-guidance and care, school performance, and work.

X-linked mental retardation (XLMR) is associated with more than 200 conditions linked to >90 genes on the X chromosome. XLMR affects approximately 1/600-1/1000 males, as well as a significant number of females.   Mutations in these genes have been shown to be an underlying cause of mental retardation, which may or may not be associated with other congenital anomalies, developmental delay, autism, dysmorphism, and numerous genetic syndromes.  One of the XLMR associated genes is ZNF711.

Mutations in the zinc finger protein 711 gene (ZNF711) have been shown to result in nonspecific mental retardation (MRXZ).  Located at Xq21.1-q21.3, the ZNF711 gene is comprised of 7 coding exons in which both point transitions and small deletions have been observed.  Mutations in ZNF711 demonstrate X-linked dominant inheritance with variable penetrance in females.  Patients with ZNF711 mutations present with moderate mental retardation and lack of additional consistent distinctive features.

Testing Benefits & Indication 

ZNF711 genetic testing may be considered for any individual with idiopathic syndromic or non-syndromic mental retardation, developmental delay, and learning disabilities with or without congenital abnormalities. 

Carrier testing for at-risk family members and prenatal testing are available for families in which a specific mutation in ZNF711 has been identified.

Test Description 

Genomic deoxyribonucleic acid (gDNA) is isolated from the patient’s specimen using a standardized kit and quantified by agarose gel electrophoresis.  If full gene sequence analysis is requested, polymerase chain reaction (PCR) is used to selectively amplify regions of gDNA corresponding to the ZNF711 gene followed by double stranded sequencing in sense and anti-sense directions to detect sequence variations. If specific mutation analysis is requested, only specific region(s) of DNA is (are) amplified by PCR and sequenced. ZNF711 exons 1-11 plus at least 20 bases into the 5’ and 3’ ends of all the introns are analyzed. The following sites are used to search for previously described ZNF711 mutations and polymorphisms: Human Gene Mutation Database (HGMD), and online search engines (e.g., PubMed).

Billing Codes 
Test Code Technique CPT Codes
3640 ZNF711 Gene Sequence Analysis 83891x1, 83894x10, 83898x9, 83904x18, 83909x18, 83912x1

 

Turnaround Time 
Technique Days
ZNF711 Gene Sequence Analysis 21-35

 

Specialty 
Genes